Data as of Q4 2025 (Dec 31, 2025)
REGN

REGENERON PHARMACEUTICALS

Institutional Ownership ยท Q4 2025

Filing: Q4 2025

REGENERON PHARMACEUTICALS (REGN) is held by 1,310 institutional investors with combined holdings of $59.9B. Major holders include VANGUARD GROUP INC, BlackRock, Inc. (BLK), STATE STREET CORP (STT, .

Institutional Holders
1,310
Total Value
$59.9B
Ownership %
75.3%